Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data

BACKGROUND: The positioning of new biologic agents for the treatment of Crohn’s disease (CD) following failure of initial anti-tumor necrosis factor (anti-TNF) therapy remains a challenge in the real world. OBJECTIVES: This study aims to investigate the real-world outcomes associated with the sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuleku, Evi, Antolin-Fontes, Beatriz, Borsi, Andras, Nissinen, Riikka, Bravatà, Ivana, Barthelmes, Jennifer Norma, Le Bars, Manuela, Lee, Jennifer, Passey, Alun, Maywald, Ulf, Deiters, Barthold, Bokemeyer, Bernd, Wilke, Thomas, Ghiani, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638528/
https://www.ncbi.nlm.nih.gov/pubmed/36353736
http://dx.doi.org/10.1177/17562848221130554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638528/
https://www.ncbi.nlm.nih.gov/pubmed/36353736
http://dx.doi.org/10.1177/17562848221130554

Ejemplares similares